We are excited to announce the opening of the virtual Sponsor Showcase where sponsors are sharing information about their products and services, their latest innovations, and have details on how to contact sponsor representatives directly with questions and/or set up one-on-one meetings with sponsor representatives! Please contact the CANNT National Office at firstname.lastname@example.org if you have any questions!
Amgen applies science to help fight serious illness and dramatically improve lives. With headquarters in ON and a research facility in BC, Amgen Canada has been an important contributor since 1991, supporting the field of Nephrology since 2002. Today, tens of thousands of Canadians use Amgen medicines every year, and thousands are enrolling in clinical studies.
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. We provide a complete solution for patients with chronic kidney failure and their caregivers, from research and development to manufacturing our dialysis products to providing therapy options within our own clinics.
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.
Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines. The company employs more than 800 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer. We are focused on developing innovative medicines in three core areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). Our bold aspiration is to improve the lives of 200 million patients by 2025.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. In Canada, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen for 83 years.
Since 1978, CardioMed Supplies Inc., has been a leading Canadian manufacturer and distributor of disposable medical devices for open heart surgery, dialysis, critical care, oncology and other specialized areas.